Geron Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Dawn Bir
Chief executive officer
US$583.3k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 1.7yrs |
| Board average tenure | 6.2yrs |
Recent management updates
No updates
Recent updates
No updates
CEO
Dawn Bir (53 yo)
less than a year
Tenure
US$583,314
Compensation
Ms. Dawn Carter Bir is a Director at Soleno Therapeutics, Inc. since August 12, 2024. She was Chief Commercial Officer of Reata Pharmaceuticals, Inc. since September 2016 and oversee marketing, market acce...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim President & Chief Executive Officer and Director | less than a year | US$583.31k | no data | |
| Executive VP | 1.7yrs | US$2.15m | 0% € 0 | |
| Executive VP & COO | 6.3yrs | US$2.81m | 0.00036% € 2.7k | |
| Executive VP & Chief Commercial Officer | less than a year | US$5.77m | 0.016% € 116.7k | |
| Executive Vice President of Research & Development | less than a year | US$7.21m | no data | |
| Vice President of Investor Relations & Corporate Communications | no data | no data | no data | |
| Executive VP | 1.8yrs | US$3.61m | 0.0042% € 31.1k | |
| Executive VP & Chief People Officer | 5.9yrs | no data | no data | |
| Executive VP & Chief Medical Officer | 2.8yrs | no data | no data |
1.7yrs
Average Tenure
57yo
Average Age
Experienced Management: 1GERN's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim President & Chief Executive Officer and Director | 6.2yrs | US$583.31k | no data | |
| Independent Director | 1.5yrs | US$589.84k | 0% € 0 | |
| Independent Director | 13.2yrs | US$586.66k | 0% € 0 | |
| Lead Independent Director | 6.2yrs | US$630.75k | 0.0053% € 39.2k | |
| Independent Director | 15yrs | US$583.32k | 0.028% € 206.9k | |
| Independent Director | 12.7yrs | US$582.47k | 0% € 0 | |
| Independent Director | 2.7yrs | US$588.25k | 0% € 0 |
6.2yrs
Average Tenure
62yo
Average Age
Experienced Board: 1GERN's board of directors are considered experienced (6.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/07 07:21 |
| End of Day Share Price | 2025/05/07 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Geron Corporation is covered by 27 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Carter Gould | Barclays |
| Peter Lawson | Barclays |
| George Zavoico | B. Riley Securities, Inc. |